Clinical Trial Update: Pharmacogenomics Study of CPT-11 as the First-line Chemotherapy for mCRC

View source ↗

Summary

A pharmacogenomics study evaluating irinotecan (CPT-11) as first-line chemotherapy for metastatic colorectal cancer, sponsored by Huazhong University of Science…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Irinotecan (Irinotecan)

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Colorectal Cancer | Status: UNKNOWN